is tagrisso a chemo drug?
Because Tagrisso is a newer-generation EGFR-tyrosine kinase inhibitor, researchers thought it might be effective against lung cancer — and it proved to be. Patients were randomly split into groups receiving a Tagrisso tablet or chemotherapy. Those receiving Tagrisso had a progression-free survival rate of 10.1 months.